Hst Global, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 10, 2020 at 03:55 pm EDT
Share
HST Global, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was USD 43,822 compared to USD 34,758 a year ago. Net loss was USD 44,028 compared to USD 43,695 a year ago. For the half year, operating loss was USD 78,640 compared to USD 71,066 a year ago. Net loss was USD 78,862 compared to USD 88,940 a year ago.
HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.
HST GLOBAL, INC. 
